EXPERIMENTAL STUDIES
Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling
Thierry Le Tourneau, MDa,
Eric Van Belle, MDa,
Delphine Corseaux, PhDa,
Benoît Vallet, MDa,
Gilles Lebuffe, MDa,
Bernard Dupuis, MDa,
Jean-Marc Lablanche, MD, FACCa,
Eugène McFadden, MRCPI, FACCa,
Christophe Bauters, MD, FACCa and
Michel E. Bertrand, MD, FACCa
a University and CHRU of Lille, Lille, France
Manuscript received January 12, 1998;
revised manuscript received September 21, 1998,
accepted November 2, 1998.
Reprint requests and correspondence: Dr. Christophe Bauters, Service de Cardiologie B, Hôpital Cardiologique, Boulevard du Professeur J Leclercq, 59037 Lille Cedex, France
OBJECTIVES
The purpose of this study was to assess the effects of L-arginine and NG-nitro-L-arginine methyl ester (L-NAME) on neointimal hyperplasia and vascular remodeling after balloon angioplasty in the hypercholesterolemic rabbit.
BACKGROUND
Restenosis after balloon angioplasty is a consequence of both neointimal hyperplasia and vessel remodeling. Nitric oxide inhibits neointimal hyperplasia, but its effect on vessel remodeling is unknown.
METHODS
Six weeks after induction of bilateral iliac atherosclerosis, 48 rabbits underwent successful angioplasty in 75 vessels. Eight rabbits (acute group) were sacrificed immediately after angioplasty. The remaining animals received either placebo (chronic control group), or a diet supplemented with either L-arginine (1.5 g/kg/day), or L-NAME (15 mg/kg/day) for 4 weeks after angioplasty.
RESULTS
The intimal area was significantly greater in the chronic control group compared to the acute group (2.60 ± 1.03 mm2 vs. 1.35 ± 0.62 mm2). This increase in intimal area was lower in the L-arginine group (1.79 ± 0.61 mm2), and greater in the L-NAME group (3.23 ± 0.92 mm2). The area circumscribed by the internal elastic lamina (IEL) increased significantly in the control group compared to the acute group (from 2.52 ± 0.66 to 3.33 ± 0.85 mm2); a more marked increase occurred in the L-NAME group (3.90 ± 0.85 mm2). By contrast, IEL area was unchanged in the L-arginine group (2.41 ± 0.62 mm2). As a result, there was no significant difference in lumen area after 4 weeks in the chronic groups (control: 0.74 ± 0.38 mm2; L-arginine: 0.50 ± 0.43 mm2; L-NAME: 0.48 ± 0.42 mm2).
CONCLUSIONS
Our results demonstrate that L-arginine inhibits whereas L-NAME stimulates neointimal hyperplasia after experimental balloon angioplasty in the hypercholesterolemic rabbit. However, the lack of vessel enlargement in the L-arginine group resulted in a similar final lumen size in the L-NAME and L-arginine groups.
|
Abbreviations and Acronyms
| | EEL | = external elastic lamina | | IEL | = internal elastic lamina | | ISDN | = isosorbide dinitrate | | L-NAME | = NG-nitro-L-arginine methyl ester | | NO | = nitric oxide |
|
This article has been cited by other articles:

|
 |

|
 |
 
C.-C. Wu, S.-C. Wen, C.-W. Yang, S.-Y. Pu, K.-C. Tsai, and J.-W. Chen
Plasma ADMA Predicts Restenosis of Arteriovenous Fistula
J. Am. Soc. Nephrol.,
January 1, 2009;
20(1):
213 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Cardounel, H. Cui, A. Samouilov, W. Johnson, P. Kearns, A.-L. Tsai, V. Berka, and J. L. Zweier
Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function
J. Biol. Chem.,
January 12, 2007;
282(2):
879 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-M. Lu, Y.-A. Ding, S.-J. Lin, W.-S. Lee, and H.-C. Tai
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
Eur. Heart J.,
November 1, 2003;
24(21):
1912 - 1919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. CONDORELLI, J. K. AYCOCK, G. FRATI, and C. NAPOLI
Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice
FASEB J,
October 1, 2001;
15(12):
2162 - 2170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Napoli, G. Cirino, P. Del Soldato, R. Sorrentino, V. Sica, M. Condorelli, A. Pinto, and L. J. Ignarro
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice
PNAS,
February 27, 2001;
98(5):
2860 - 2864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kawashima, T. Yamashita, M. Ozaki, Y. Ohashi, H. Azumi, N. Inoue, K.-i. Hirata, Y. Hayashi, H. Itoh, and M. Yokoyama
Endothelial NO Synthase Overexpression Inhibits Lesion Formation in Mouse Model of Vascular Remodeling
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2001;
21(2):
201 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Cooke
Does ADMA Cause Endothelial Dysfunction?
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2000;
20(9):
2032 - 2037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pasterkamp, D. P.V de Kleijn, and C. Borst
Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications
Cardiovasc Res,
March 1, 2000;
45(4):
843 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens
Gene therapy in the cardiovascular system: an update
Cardiovasc Res,
December 1, 1999;
44(3):
498 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Six, E. Van Belle, R. Bordet, D. Corseaux, J. Callebert, B. Dupuis, C. Bauters, and M. E. Bertrand
L-Arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury
Cardiovasc Res,
August 15, 1999;
43(3):
731 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Napoli, G. Aldini, J. L. Wallace, F. de Nigris, R. Maffei, P. Abete, D. Bonaduce, G. Condorelli, F. Rengo, V. Sica, et al.
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis
PNAS,
February 5, 2002;
99(3):
1689 - 1694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Sierevogel, E. Velema, P. P. de Jaegere, D. P. de Kleijn, C. Borst, and G. Pasterkamp
Minimal Duration of Oral Matrix Metalloproteinase Inhibition to Prevent Constrictive Arterial Remodeling after Balloon Dilation in the Pig
Radiology,
February 1, 2002;
222(2):
468 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|